GlassScriptPhysician profile
Charles S Jervey
NPI 1801865365
$1,270.47
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,164 · 2020: $63.82 · 2022: $27.06 · 2023: $15.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $345.58 | 2019 | |
| Emd Serono, INC. | $194.83 | 2019-2020 | |
| Acorda Therapeutics, INC | $91.63 | 2019 | |
| Genentech USA, INC. | $75.41 | 2019 | |
| Ucb, INC. | $74.85 | 2019 | |
| Acadia Pharmaceuticals INC | $72.96 | 2019 | |
| Boston Scientific Corporation | $56.89 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $55.10 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $48.07 | 2019 | |
| Promius Pharma LLC | $43.84 | 2019 | |
| Mallinckrodt Enterprises LLC | $29.68 | 2019 | |
| Alexion Pharmaceuticals, INC. | $27.81 | 2019 | |
| Grifols USA, LLC | $26.26 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $21.22 | 2019 | |
| Lundbeck LLC | $19.23 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $16.48 | 2019 | |
| Mallinckrodt Hospital Products INC. | $15.95 | 2023 | Acthar |
| Amneal Pharmaceuticals LLC | $14.54 | 2019 | |
| Allergan, INC. | $14.50 | 2019 | |
| Kyowa Kirin, INC. | $14.08 | 2020 | |
| Amgen INC. | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Jervey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.